Loading: 100%
Diplomat Pharmacy, Inc. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 1,827 (as per Q3 2016)no data available
Sector Drug Manufacturers, HealthcareDrug Manufacturers, Healthcareno data available
Ticker DPLOno data available
Financial year endsFY ends End of Decemberno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common Shares,AVotingCommonStockNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,07,515,022,530,0
datesClosing price (adj.)
13.10.201720.31
11.10.201720.94
04.10.201721.25
27.09.201721.42
20.09.201720.03
13.09.201718.35
06.09.201716.84
30.08.201716.50
23.08.201716.44
16.08.201716.57
09.08.201715.91
02.08.201715.52
26.07.201715.52
19.07.201715.23
12.07.201715.12
05.07.201714.81
27.06.201715.30
20.06.201718.21
13.06.201718.78
06.06.201718.17
30.05.201717.23
23.05.201717.61
16.05.201717.93
09.05.201717.84
02.05.201716.26
25.04.201715.49
18.04.201714.76
11.04.201714.94
04.04.201714.65
28.03.201715.37
21.03.201715.09
14.03.201714.99
07.03.201714.57
28.02.201713.55
21.02.201714.55
14.02.201714.65
07.02.201715.01
31.01.201713.74
24.01.201713.15
17.01.201713.75
10.01.201712.96
03.01.201712.70
27.12.201613.06
19.12.201613.35
12.12.201613.01
05.12.201614.40
28.11.201615.09
21.11.201614.73
14.11.201614.90
07.11.201613.29
31.10.201623.17
24.10.201628.95
17.10.201627.79
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
20.31n/a
Market Capitalisation
in million USD
1,355n/a
Enterprise Value
in million USD
1,447n/a
Common Shares Outstanding
as per Sep 30, 2016
66,711,874n/a
Preferred Shares Outstanding
as per Sep 30, 2016
n/a
Average Basic Shares Outstanding
TTM
65,437,585n/a
Average Diluted Shares Outstanding
TTM
67,891,557n/a
Index Membership
n/a
Business Summary
Diplomat Pharmacy Inc is a provider of pharmaceutical drugs in the United States. It generates its revenue through the sale of prescriptions drugs for serious diseases such as hepatitis and multiple sclerosis.
no data available
Key Financials & Ratios (all figures TTM as per Sep 30, 2016, million USD, full statements further below)
Profit & Loss
Revenues 4,252n/a
Gross Profit 318n/a
Operating Income 47n/a
EBITDA 93n/a
Net Profit 33n/a
Balance Sheet
Cash and Cash Equivalents 17n/a
Receivables 289n/a
Total Current Assets 529n/a
PP&E 20n/a
Total Assets 1,130n/a
Accounts Payable 332n/a
Current Debt 7n/a
Total Current Liabilities 403n/a
Long-Term Debt 102n/a
Total Liabilities 517n/a
Total Equity 613n/a
Cash Flow
Depreciation & Amortisation 46n/a
Change in Working Capital -30n/a
Operating Cash Flow 58n/a
Net Change in PP&E and Intangibles -7n/a
Investing Cash Flow -85n/a
Dividends Paid 0n/a
Financing Cash Flow 28n/a
Total Change in Cash 1n/a
Free Cash Flow 44n/a
Profitability Ratios
Gross Margin 7.5%n/a
Operating Margin 1.1%n/a
Net Profit Margin 0.7%n/a
Return on Equity 4.8%n/a
Return on Assets 2.6%n/a
Per Share Figures
Basic EPS 0.50n/a
Diluted EPS 0.49n/a
Sales per Share 64.98n/a
Book Value per Share 9.37n/a
FCF per Share 0.67n/a
Dividends per Share 0.00n/a
Price Multiples
Price to Earnings Ratio 40.35n/a
Price to Sales Ratio 0.31n/a
Price to Book Value 2.17n/a
Price to Free Cash Flow 30.10n/a
Valuation Metrics
EV/EBITDA 15.50n/a
EV/Sales 0.34n/a
Book to Market Value 0.45n/a
Other Ratios
Current Ratio 131.3%n/a
Liabilities to Equity Ratio 84.3%n/a
Debt to Assets Ratio 9.6%n/a
Profit & Loss StatementP&L data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Revenue
1,127
1,515
2,215
3,367
Sales & Services Revenue
0
0
0
0
Financing Revenue
0
0
0
0
Other Revenue
0
0
0
0
Cost of revenue
-1,058
-1,426
-2,075
-3,103
Cost of Goods & Services
0
0
0
0
Cost of Financing Revenue
0
0
0
0
Cost of Other Revenue
0
0
0
0
Gross Profit
69
89
140
263
Other Operating Income
0
0
0
0
Operating Expenses
-64
-78
-128
-217
Selling, General & Administrative
-64
-78
-128
-217
Selling & Marketing
0
0
0
0
General & Administrative
0
0
0
0
Research & Development
0
0
0
0
Depreciation & Amortization
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
Other Operating Expense
0
0
0
0
Operating Income (Loss)
5
11
13
46
Non-Operating Income (Loss)
-1
-2
-1
-5
Interest Expense, net
-1
-2
-3
-5
Interest Expense
0
0
0
0
Interest Income
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
Other Non-Operating Income (Loss)
0
0
1
0
Pretax Income (Loss), Adjusted
4
9
11
41
Abnormal Gains (Losses)
-7
-35
-2
0
Acquired In-Process R&D
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
Abnormal Derivatives
0
0
0
0
Disposal of Assets
0
0
0
0
Early extinguishment of Debt
0
0
0
0
Asset Write-Down
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
Sale of Business
0
0
0
0
Legal Settlement
0
0
0
0
Restructuring Charges
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
Insurance Settlement
0
0
0
0
Other Abnormal Items
0
0
0
0
Pretax Income (Loss)
-3
-26
9
41
Income Tax (Expense) Benefit, net
0
0
-5
-16
Current Income Tax
0
0
0
0
Deferred Income Tax
0
0
0
0
Tax Allowance/Credit
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
Income (Loss) from Continuing Operations
-3
-26
5
25
Net Extraordinary Gains (Losses)
0
0
0
0
Discontinued Operations
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
Income (Loss) Including Minority Interest
-3
-26
5
25
Minority Interest
0
0
0
1
Net Income
-3
-26
5
26
Preferred Dividends
0
0
0
0
Other Adjustments
0
0
0
0
Net Income Available to Common Shareholders
-3
-26
4
26
Remarks
restated on Mar 3, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 90% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Assets
Cash, Cash Equivalents & Short Term Investments
n/a
9
18
28
Cash & Cash Equivalents
n/a
9
18
28
Short Term Investments
n/a
0
0
0
Accounts & Notes Receivable
n/a
110
155
255
Accounts Receivable, Net
n/a
110
155
255
Notes Receivable, Net
n/a
0
0
0
Unbilled Revenues
n/a
0
0
0
Inventories
n/a
56
111
166
Raw Materials
n/a
0
0
0
Work In Process
n/a
0
0
0
Finished Goods
n/a
0
0
0
Other Inventory
n/a
0
0
0
Other Short Term Assets
n/a
2
7
13
Prepaid Expenses
n/a
2
5
7
Derivative & Hedging Assets
n/a
0
0
0
Assets Held-for-Sale
n/a
0
0
0
Deferred Tax Assets
n/a
0
2
5
Income Taxes Receivable
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Miscellaneous Short Term Assets
n/a
0
0
0
Total Current Assets
n/a
178
291
461
Property, Plant & Equipment, Net
n/a
12
13
17
Property, Plant & Equipment
n/a
0
0
0
Accumulated Depreciation
n/a
0
0
0
Long Term Investments & Receivables
n/a
6
4
5
Long Term Investments
n/a
0
0
0
Long Term Marketable Securities
n/a
0
0
0
Long Term Receivables
n/a
0
0
0
Other Long Term Assets
n/a
16
82
519
Intangible Assets
n/a
14
58
262
Goodwill
n/a
2
23
256
Other Intangible Assets
n/a
0
0
0
Prepaid Expense
n/a
0
0
0
Deferred Tax Assets
n/a
0
0
0
Derivative & Hedging Assets
n/a
0
0
0
Prepaid Pension Costs
n/a
0
0
0
Discontinued Operations
n/a
0
0
0
Investments in Affiliates
n/a
0
0
0
Miscellaneous Long Term Assets
n/a
1
1
1
Total Noncurrent Assets
n/a
34
99
541
Total Assets
n/a
212
390
1,002
Liabilities and owners' equity
Payables & Accruals
n/a
142 142353000
202 202495000
297 296587000
Accounts Payable
n/a
142 142353000
202 202495000
297 296587000
Accrued Taxes
n/a
0 0
0 0
0 0
Interest & Dividends Payable
n/a
0 0
0 0
0 0
Other Payables & Accruals
n/a
0 0
0 0
0 0
Short Term Debt
n/a
7 6693000
0 0
6 6000000
Short Term Borrowings
n/a
0 0
0 0
0 0
Short Term Capital Leases
n/a
0 0
0 0
0 0
Current Portion of Long Term Debt
n/a
0 0
0 0
0 0
Other Short Term Liabilities
n/a
68 67621000
13 12933000
69 69315000
Deferred Revenue
n/a
0 0
0 0
0 0
Derivatives & Hedging
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
n/a
68 67621000
13 12933000
69 69315000
Total Current Liabilities
n/a
217 216667000
215 215428000
372 371902000
Long Term Debt
n/a
19 18849000
0 0
107 106706000
Long Term Borrowings
n/a
0 0
0 0
0 0
Long Term Capital Leases
n/a
0 0
0 0
0 0
Other Long Term Liabilities
n/a
54 54043000
6 5931000
7 7425000
Accrued Liabilities
n/a
0 0
0 0
0 0
Pension Liabilities
n/a
0 0
0 0
0 0
Pensions
n/a
0 0
0 0
0 0
Other Post-Retirement Benefits
n/a
0 0
0 0
0 0
Deferred Compensation
n/a
0 0
0 0
0 0
Deferred Revenue
n/a
0 0
0 0
0 0
Deferred Tax Liabilities
n/a
0 0
1 518000
7 7425000
Derivatives & Hedging
n/a
0 0
0 0
0 0
Discontinued Operations
n/a
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
n/a
54 54043000
5 5413000
0 0
Total Noncurrent Liabilities
n/a
73 72892000
6 5931000
114 114131000
Total Liabilities
n/a
290 289559000
221 221359000
486 486033000
Preferred Equity
n/a
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
n/a
4 4186000
159 158794000
481 480841000
Common Stock
n/a
0 0
0 0
0 0
Additional Paid in Capital
n/a
0 0
0 0
0 0
Other Share Capital
n/a
0 0
0 0
0 0
Treasury Stock
n/a
0 0
0 0
0 0
Retained Earnings
n/a
-82 -81972000
5 5354000
31 31130000
Other Equity
n/a
0 0
0 0
0 0
Equity Before Minority Interest
n/a
-78 -77786000
164 164148000
512 511971000
Minority Interest
n/a
0 0
5 4579000
4 3575000
Total Equity
n/a
-78 -77786000
169 168727000
516 515546000
Total Liabilities & Equity
n/a
212 211773000
390 390086000
1,002 1001579000
Remarks restated on n/a restated on Mar 3, 2015 n/a restated on Feb 29, 2016 n/a restated on Nov 2, 2016 n/a
Cash Flow StatementCF data quality: 100% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '12FY '13FY '14FY '15
Net Income/Starting Line
-3
-26
5
25
Net Income
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
Other Adjustments
0
0
0
0
Depreciation & Amortization
4
4
8
31
Non-Cash Items
9
38
11
-11
Stock-Based Compensation
0
0
0
0
Deferred Income Taxes
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
Change in Working Capital
-5
-10
-33
-15
(Increase) Decrease in Accounts Receivable
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
Cash from Operating Activities
5
6
-10
29
Change in Fixed Assets & Intangibles
-3
-1
-1
-5
Disposition of Fixed Assets & Intangibles
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
Increase in Long Term Investment
0
0
0
0
Net Cash From Acquisitions & Divestitures
-2
-15
-56
-295
Net Cash from Divestitures
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
Cash for Joint Ventures
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
Other Investing Activities
0
-5
-9
-12
Net Cash From Discontinued Operations (investing)
0
0
0
0
Cash from Investing Activities
-5
-20
-66
-312
Dividends Paid
-11
-2
0
0
Cash From (Repayment of) Debt
15
25
-88
117
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
Cash From Long Term Debt
0
0
0
0
Cash From (Repurchase of) Equity
-3
0
179
198
Increase in Capital Stock
0
0
232
198
Decrease in Capital Stock
-3
0
-53
0
Other Financing Activities
-2
0
-6
-24
Net Cash From Discontinued Operations (financing)
0
0
0
0
Cash from Financing Activities
0
23
85
292
Net Cash Before Disc. Operations and FX
0
9
9
10
Change in Cash from Disc. Operations and Other
0
0
0
0
Net Cash Before FX
0
9
9
10
Effect of Foreign Exchange Rates
0
0
0
0
Net Changes in Cash
0
9
9
10
Remarks
restated on Mar 3, 2015 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
restated on Feb 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
Sumo